CC |
CC cells |
miR-221-3p |
Lymphangiogenesis and lymphatic metastasis |
VASH1 |
Zhou et al. [55] |
CC |
CC cells |
miR-221-3p |
Proliferation, invasion, migration and angiogenesis |
MAPK10 |
Zhang et al. [56] |
CC |
CC cells |
miR-221-3p |
Angiogenesis |
THBS2 |
Wu et al. [57] |
CC |
Human bone marrow mesenchymal stem cells |
miR-144-3p |
Proliferation, invasion and migration |
CEP55 |
Meng et al. [70] |
CC |
CC cells |
miR-1468-5p |
Immunosuppressive |
JAK2/STAT3 |
Zhou et al. [116] |
CC |
Cancer-associated fibroblast |
miR-10a-5p |
Angiogenesis |
TBX5 mediated Hh signaling |
Zhang et al. [67] |
CC |
DDP‑resistant Hela cells |
HNF1A‑AS1 |
Proliferation, drug resistance, apoptosis |
microRNA-34b/TUFT1 |
Luo et al. [83] |
CC |
CC cells |
TUG1 |
Angiogenesis |
angiogenesis-related genes |
Lei et al. [59] |
OC |
Hypoxic macrophages |
miR-223 |
Drug resistance |
PTEN-PI3K/AKT |
Zhu et al. [117] |
OC |
Human ovarian surface epithelial cells |
miR‐124 |
Extracellular matrix remodeling |
SPHK1 |
Zhang et al. [71] |
OC |
OC cells |
miR-99a-5p |
Invasion |
HPMCs |
Yoshimura et al. [96] |
OC |
SKOV3 |
miR-205 |
Proliferation, migration, invasion, apoptosis and EMT progression |
VEGFA |
Wang et al. [94] |
OC |
OC cells or serum |
miR-205 |
Angiogenesis and metastasis |
PTEN-AKT |
He et al. [95] |
OC |
MDA-MB-231 |
miR-454 |
OC cell growth |
PRRT2 |
Wang et al. [98] |
OC |
Human adipose mesenchymal stem cells |
miRNAs |
Apoptosis |
pro-apoptotic signaling molecules |
Reza et al. [118] |
OC |
SKOV3 |
miR-141-3p |
Angiogenesis |
JAK/STAT3 |
Masoumi-Dehghi et al. [58] |
OC |
IOSE-80 |
miR-34b |
Proliferation and EMT |
Notch2 |
Lu et al. [99] |
OC |
SKOV3/DDP cells |
miR-30a-5p |
Drug resistance |
SOX9 |
Liu et al. [119] |
OC |
OC cells |
miR-1246 |
Drug resistance |
Cav1/p-gp/M2-type macrophage axis |
Kanlikilicer et al. [62] |
OC |
TWEAK-stimulated macrophages |
miR-7 |
Metastasis |
EGFR/AKT/ERK1/2 |
Hu et al. [101] |
OC |
Cancer-associated fibroblast cells |
miR-98-5p |
Proliferation, cell cycle and drug resistance |
CDKN1A |
Guo et al. [65] |
OC |
Cancer-associated adipocytes and fibroblasts cells |
miR-21 |
Apoptosis and drug resistance |
APAF1 |
Au Yeung et al. [66] |
OC |
Mesenchymal stem cells |
miR-424 |
Tumorigenesis and angiogenesis |
MYB |
Li et al. [69] |
OC |
Serum |
circFoxp1 |
Drug resistance |
miR-22 and miR-150-3p/ CEBPG and FMNL3 |
Luo et al. [97] |
EC |
Cancer-associated fibroblasts cells |
miR-320a |
Proliferation |
HIF1α/VEGFA |
Zhang et al. [108] |
EC |
Hypoxic KEL cells |
miR-21 |
M2 polarization |
IL-10 and CD206 |
Xiao et al. [61] |
EC |
Cancer-associated fibroblasts cells |
miR‐148b |
Invasion and metastasis |
DNMT1 |
Li et al. [109] |
EC |
Serum |
miR-27a-5p |
Migration and invasion |
SMAD4 |
Che et al. [120] |
EC |
Mesenchymal stem cells |
miR-499a-5p |
Proliferation, tumor growth and angiogenesis |
VAV3 |
Jing et al. [121] |
EC |
EC cells |
DLEU1 |
Proliferation, migration, invasion |
microRNA/E2F3 |
Jia et al. [110] |